CPVT-associated CaM mutations did not affect amplitude, inter-transient interval, ER load, rise and fall rate of RyR2-mediated Ca2+ release events compared to CaM-WT. This evidence concerns the gene CALM2 and catecholaminergic polymorphic ventricular tachycardia.